Funded Startups in Hamerkaz
Disclosed round sizes in Hamerkaz span a wide range, but the top end is concentrated: ZOOZ Power’s $180M (2025-07-29) is the only disclosed round above $10…
Disclosed round sizes in Hamerkaz span a wide range, but the top end is concentrated: ZOOZ Power’s $180M (2025-07-29) is the only disclosed round above $100M, and it is dramatically larger than the next-largest disclosed amounts shown (Nostromo at $306M on 2024-12-09 and Fetcherr at $42M on 2025-09-28). At the lower edge, the smallest disclosed amount is $170K for Kadimastem (2025-07-17), well below the rest of the visible disclosed figures. Two cluster patterns stand out: many rounds cluster in mid-2025 (multiple dates in May–July 2025), while several appear tightly within late 2024 (e.g., 2024-11-07 through 2024-12-27 includes Pentera $60M on 2025-03-12? not; rather, includes Magenta Medical $105M on 2024-07-23 and Nostromo $306M on 2024-12-09). The list also shows a sector concentration: biotechnology appears in 6 entries (IBI-Ag, Neurolief, CanFite BioPharma, Enlivex Therapeutics, DreaMed? no; BIOMx, plus others), and “Series Unknown” is common—10 rows list “Series Unknown,” and 5 rows are “undisclosed.” Across the 50 rows shown, rounds run from 2024-04-02 (Velox) through 2025-11-19 (Chargeflow).
Most recent rounds
50 shownRelated listings
Frequently asked
What stands out about disclosed round sizes in this Hamerkaz list?
The largest disclosed amount is ZOOZ Power’s $180M on 2025-07-29, which sits far above most other disclosed rounds; the next-largest disclosed amounts shown are in the tens of millions (e.g., Fetcherr $42M on 2025-09-28 and Speedata $44M on 2025-06-03), while the minimum disclosed amount is $170K for Kadimastem on 2025-07-17.
Are there time-window clusters in the most recent 50 rounds?
Yes. A dense mid-2025 run includes multiple May–July 2025 closings such as Wi Charge ($20M, 2025-05-15), Speedata ($44M, 2025-06-03), and ZOOZ Power ($180M, 2025-07-29), while late 2024 also clusters around major checks like Nostromo ($306M, 2024-12-09) and D-Fend Solutions ($31M, 2024-12-04).
Do any sectors dominate these funded companies?
Biotechnology is the clearest concentration, appearing repeatedly (e.g., IBI-Ag $4M on 2025-11-16, CanFite BioPharma $15M on 2025-07-28, BIOMx $12M on 2025-02-26, and Enlivex Therapeutics $15M on 2024-05-28). Other sectors appear, but not at the same frequency in the visible rows.
How does the stage disclosure pattern look: Series Unknown vs named stages?
Stage labeling is uneven: 10 of the 50 rows are marked “Series Unknown,” and 5 rows are “undisclosed” by amount (e.g., FEMSelect on 2025-05-13 and Fincom on 2025-05-13 both show undisclosed amounts). By contrast, named stages like Series A, B, C, and D do appear, including Pentera’s Series D ($60M on 2025-03-12) and Fetcherr’s Series C ($42M on 2025-09-28).
Any outliers worth spotlighting beyond the single largest round?
Besides the top $180M check (ZOOZ Power, 2025-07-29), there are notable high-disclosure outliers and a low-disclosure tail: Nostromo posts $306M on 2024-12-09, while Kadimastem is the smallest disclosed amount at $170K on 2025-07-17. These extremes bookend the distribution more than typical next-largest figures in the tens of millions.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.